Results 271 to 280 of about 252,043 (349)
Ferroptosis-induced remodeling of glycosylation the immune microenvironment and improves survival in pancreatic cancer. [PDF]
Tan H, Zhang H, Gao J, Wang L, Luan X.
europepmc +1 more source
ABSTRACT Background Current evidence on incidence and progression rate of diabetic retinopathy reveals disparities across Australasia, and no pooled estimates are available to guide region‐wide planning. This review and meta‐analysis assesses the overall incidence, determinants and progression of diabetic retinopathy in Australasia.
Getasew Alemu Mersha +6 more
wiley +1 more source
Nonsurgical Periodontal Therapy for Diabetes Patients with Periodontal Disease. [PDF]
Moya-Villaescusa MJ +4 more
europepmc +1 more source
Hepatocyte TrkB is identified as a critical gatekeeper against MASH‐related fibrosis. Mechanistically, TrkB inhibits the TGFβ/SMAD3/FOS axis to suppress CCL2 secretion, thereby blocking pathogenic macrophage recruitment and ameliorating liver fibrosis.
Yueying Chen +11 more
wiley +1 more source
<i>N</i>-Glycoproteomic Portraits of <i>Bothrops</i> Snake Venoms Reveal Evolutionarily Conserved and Divergent Phenotypes. [PDF]
Andrade-Silva D +8 more
europepmc +1 more source
Abstract Introduction Evidence shows that ethnicity affects the risk of progression of prediabetes to type 2 diabetes(T2D) or regression to normoglycaemia However, little is known about progression rates among sub‐Saharan African populations or whether geographical context affects risk variations.
Emmanuel Bannerman‐Williams +8 more
wiley +1 more source
GlycoRNA in cancer immune regulation and progression: biological mechanisms and translational therapeutic prospects. [PDF]
Xu M, Wang R, Li J, Liu J, Jia D, Yu Y.
europepmc +1 more source
Abstract Introduction Achieving and sustaining target glycated haemoglobin (HbA1c) levels is fundamental in the management of type 2 diabetes (T2D). We here aimed to assess whether initial dual oral therapy outperforms monotherapy in reaching glycaemic targets in patients with treatment‐naive or early‐stage T2D.
Mairead Kelly +5 more
wiley +1 more source
Biochemical characterisation and substrate-specific proteolytic diversity of venom metalloproteinases in African puff adders. [PDF]
Wilkinson MC +11 more
europepmc +1 more source

